OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021
Joseph J. Palamar, Daniel Ciccarone, Caroline Rutherford, et al.
Drug and Alcohol Dependence (2022) Vol. 234, pp. 109398-109398
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

The Overdose Crisis among U.S. Adolescents
Joseph Friedman, Scott E. Hadland
New England Journal of Medicine (2024) Vol. 390, Iss. 2, pp. 97-100
Closed Access | Times Cited: 29

Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022
Manuel Cano, Raminta Daniulaityte, Flavio F. Marsiglia
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2350630-e2350630
Open Access | Times Cited: 24

Testing the test strips: laboratory performance of fentanyl test strips
John C. Halifax, Lilly Lim, Daniel Ciccarone, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14

The public health risks of counterfeit pills
Joseph Friedman, Daniel Ciccarone
The Lancet Public Health (2025) Vol. 10, Iss. 1, pp. e58-e62
Open Access | Times Cited: 1

Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021
Joseph J. Palamar, Linda B. Cottler, Bruce A. Goldberger, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 471-480
Open Access | Times Cited: 48

The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions
Cayley Russell, Justine Law, Matthew Bonn, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103933-103933
Open Access | Times Cited: 37

Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl
H. Elizabeth Bird, Andrew S. Huhn, Kelly E. Dunn
Journal of Addiction Medicine (2023) Vol. 17, Iss. 5, pp. 503-508
Closed Access | Times Cited: 31

Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021
Julie O’Donnell, Lauren J. Tanz, Kimberly D. Miller, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 35, pp. 949-956
Open Access | Times Cited: 26

Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study
Joseph Friedman, Morgan Godvin, Caitlin Molina, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 110819-110819
Open Access | Times Cited: 23

A Bibliometric Analysis of Cannabis-Related Research from 2010 To 2022
Chaimae Haboubi, Yahya El Hammoudani, Nidal Jaradat, et al.
Deleted Journal (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 13

Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco
Daniel Ciccarone, Nicole Holm, Jeff Ondocsin, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303403-e0303403
Open Access | Times Cited: 12

National and regional trends in fentanyl seizures in the United States, 2017–2023
Joseph J. Palamar, Nicole D. Fitzgerald, Thomas H. Carr, et al.
International Journal of Drug Policy (2024), pp. 104417-104417
Closed Access | Times Cited: 9

Developing Aptamer-Based Colorimetric Opioid Tests
Juan Canoura, Obtin Alkhamis, Matthew Venzke, et al.
JACS Au (2024) Vol. 4, Iss. 3, pp. 1059-1072
Open Access | Times Cited: 7

Public health surveillance of new psychoactive substances: recent developments
Nicole D. Fitzgerald, Linda B. Cottler, Joseph J. Palamar
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 270-276
Closed Access | Times Cited: 7

Synthetic opioids: a review and clinical update
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 29

The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia
Jeff Ondocsin, Nicole Holm, Sarah G. Mars, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18

Part I: Missouri's Fentanyl Poisonings Rise to Record Levels.
William V. Stoecker, Colin L Smith, Elizabeth Connors
PubMed (2023) Vol. 119, Iss. 6, pp. 489-493
Closed Access | Times Cited: 17

Fentanyl and Fentanyl Analog Screening Using ASAP‐MS With LiveID Confirmation
Karen A. Reyes Monroy, Rachel Koerber, Guido F. Verbeck
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 9
Open Access

Use of Illegally Manufactured Fentanyl in the United States: Current Trends
Nicole D. Fitzgerald, Joseph J. Palamar, Linda B. Cottler
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access

The Prevention Education Partnership: A Public–Academic Partnership to Expand Overdose Education and Naloxone Training in New York City Public Schools
Larissa K. Laskowski, Mehrdad Khezri, Alex S. Bennett, et al.
Health Promotion Practice (2025)
Closed Access

An analysis of the size of law enforcement seizures of illicit fentanyl in the United States, 2018–2023
Joseph J. Palamar, Nicole D. Fitzgerald, Thomas H. Carr
Drug and Alcohol Review (2025)
Closed Access

The Fourth Wave of the Opioid Epidemic: Increasing Combination of Fentanyl With Stimulants
Katie Diekhans, Jihau Yu, Sue Pearring, et al.
American Journal of Public Health (2025) Vol. 115, Iss. 4, pp. 555-565
Closed Access

Page 1 - Next Page

Scroll to top